✦ LIBER ✦

Elevated serum chromogranin A in patients with hepatocellular carcinoma

✍ Scribed by N. Leone; R. Pellicano; F. Brunello; M. Rizzetto; A. Ponzetto

Publisher: Springer
Year: 2002
Tongue: English
Weight: 53 KB
Volume: 2
Category: Article
ISSN: 0372-8722
DOI: 10.1007/s102380200016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated chromogranin A (CgA) serum leve

Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer

✍ Michele Malaguarnera; Erika Cristaldi; Lisa Cammalleri; Valentina Colonna; Helga 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Chromogranin A (CgA) serum level as a ma

Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients

✍ Michele Malaguarnera; Marco Vacante; Rosangela Fichera; Alessandro Cappellani; E 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Serum erythropoietin concentrations in p

Serum erythropoietin concentrations in patients with hepatocellular carcinoma

✍ Michael C. Kew; James W. Fisher 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

Serum fatty acids in patients with hepat

Serum fatty acids in patients with hepatocellular carcinoma

✍ Okazaki, N. ;Araki, F. ;Hattori, N. 📂 Article 📅 1972 🏛 Springer-Verlag 🌐 English ⚖ 60 KB

Serum Amino Acid Levels in Patients With

Serum Amino Acid Levels in Patients With Hepatocellular Carcinoma

✍ Akiharu Watanabe; Toshihiro Higashi; Tatsuro Sakata; Hideo Nagashima 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 784 KB

Elevated levels of serum aldolase A in p

Elevated levels of serum aldolase A in patients with renal cell carcinoma

✍ Takashi, M. ;Zhu, Y. ;Nakano, Y. ;Miyake, K. ;Kato, K. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 371 KB

To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha